Atrium Innovations赞助的临床试验
总计1682个结果
-
SCRI Development Innovations, LLCNovartis完全的
-
Telix Pharmaceuticals (Innovations) Pty Limited主动,不招人
-
Telix Pharmaceuticals (Innovations) Pty Limited完全的
-
SCRI Development Innovations, LLCPfizer撤销
-
SCRI Development Innovations, LLCIpsen终止
-
SCRI Development Innovations, LLCGlaxoSmithKline终止
-
AstraZenecaSCRI Development Innovations, LLC完全的
-
SCRI Development Innovations, LLCGlaxoSmithKline终止HER2 Positive Esophagogastric Cancer美国
-
SCRI Development Innovations, LLCGlaxoSmithKline完全的
-
SCRI Development Innovations, LLCBayer完全的
-
SCRI Development Innovations, LLCNovartis撤销
-
SCRI Development Innovations, LLCBiogen完全的
-
SCRI Development Innovations, LLCGlaxoSmithKline完全的
-
SCRI Development Innovations, LLCNovartis完全的
-
Telix Pharmaceuticals (Innovations) Pty Limited完全的
-
SCRI Development Innovations, LLCNovartis完全的
-
SCRI Development Innovations, LLCPfizer完全的
-
SCRI Development Innovations, LLCNovartis撤销
-
SCRI Development Innovations, LLCAmgen完全的
-
SCRI Development Innovations, LLCBayer完全的
-
SCRI Development Innovations, LLCNovartis完全的
-
SCRI Development Innovations, LLCBayer完全的
-
SCRI Development Innovations, LLCNovartis完全的